| Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe |
GENUPI, NCT01577069: Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir |
|
|
| Completed | N/A | 73 | Europe | | Association HGE CHU Bordeaux Sud, University Hospital, Bordeaux | Chronic Hepatitis C | 01/13 | 01/13 | | |
NCT02113631: Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir |
|
|
| Completed | N/A | 50 | US | Telaprevir, INCIVEK, Boceprevir, Victrelis, Peg-IFN, Peg-Interferon alfa-2a, Pegasys, Ribavirin, Copegus | Louis Stokes VA Medical Center | Hepatitis C, Chronic, Cirrhosis | 04/13 | 04/13 | | |
| Completed | N/A | 408 | US, Canada, Europe | telaprevir | Vertex Pharmaceuticals Incorporated, Tibotec Pharmaceutical Limited | Hepatitis C | 12/13 | 12/13 | | |
|
CUPIC, NCT01514890: French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin |
|
|
| Completed | N/A | 675 | Europe | | ANRS, Emerging Infectious Diseases | Chronic Hepatitis C | 03/14 | 03/14 | | |
|
|
|
|
|
|
|
ETIM, NCT01641094: Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms |
|
|
| Completed | N/A | 20 | Europe | | Foundation for Liver Research, Janssen-Cilag B.V. | Chronic Hepatitis C | 06/14 | 12/14 | | |
| Terminated | N/A | 8 | Europe | Diagnostic: protocol designed to evaluate one or more interventions aimed at identifying a disease or health condition | University Hospital, Grenoble | C Hepatitis, Tri Therapy | 10/14 | | | |
NCT01980290: Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C |
|
|
| Completed | N/A | 50 | Europe | | Janssen Pharmaceutica N.V., Belgium | Hepatitis, Chronic | 02/15 | 02/15 | | |
NCT01447446: An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C |
|
|
| Completed | N/A | 4442 | Europe, RoW | Peg-IFN Alfa-2a, Peg-IFN Alfa-2b, Ribavirin, Boceprevir, Telaprevir | Hoffmann-La Roche | Hepatitis C, Chronic | 07/15 | 07/15 | | |
| No Longer Available | N/A | | Europe, RoW | Telaprevir + peginterferon alfa + ribavirin, experimental, peginterferon alfa + ribavirin | Janssen-Cilag International NV | Hepatitis C | | | | |
|
|
|
|
|
|
|
|
|
